Holen Sie sich die Stockscreener-App
26.73
1.66%
-0.45
Handel nachbörslich:
26.20
-0.53
-1.98%
Schlusskurs vom Vortag:
$27.18
Offen:
$27.19
24-Stunden-Volumen:
773.66K
Relative Volume:
1.21
Marktkapitalisierung:
$1.20B
Einnahmen:
$681.75M
Nettoeinkommen (Verlust:
$70.47M
KGV:
18.43
EPS:
1.45
Netto-Cashflow:
$173.19M
1W Leistung:
-0.45%
1M Leistung:
+16.52%
6M Leistung:
+13.60%
1J Leistung:
+76.55%
1-Tages-Spanne:
$26.52
$27.64
1-Wochen-Bereich:
$26.17
$27.64
52-Wochen-Spanne:
$12.61
$27.98
Pacira Biosciences Inc Stock (PCRX) Company Profile
Firmenname
Pacira Biosciences Inc
Sektor
Telefon
650-242-8052
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Vergleichen Sie PCRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCRX
Pacira Biosciences Inc
|
26.73 | 1.22B | 681.75M | 70.47M | 173.19M | 1.45 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Hochstufung | Truist | Hold → Buy |
| 2025-01-30 | Hochstufung | Truist | Sell → Hold |
| 2024-08-13 | Herabstufung | Truist | Buy → Sell |
| 2024-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2024-08-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-08-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-08-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-07-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-03-07 | Fortgesetzt | JP Morgan | Overweight |
| 2023-12-20 | Eingeleitet | Raymond James | Outperform |
| 2023-08-03 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-01-31 | Fortgesetzt | Wedbush | Outperform |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-01-03 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-26 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-21 | Fortgesetzt | JP Morgan | Neutral |
| 2021-04-09 | Eingeleitet | Berenberg | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-11 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2021-01-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-09-21 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-06 | Bestätigt | Needham | Buy |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-04-07 | Eingeleitet | Northland Capital | Outperform |
| 2020-03-20 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-02-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2019-11-06 | Eingeleitet | BTIG Research | Buy |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-06 | Hochstufung | Mizuho | Underperform → Neutral |
| 2019-05-02 | Hochstufung | Stifel | Sell → Hold |
| 2019-02-01 | Herabstufung | Mizuho | Neutral → Underperform |
| 2018-08-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-21 | Bestätigt | Mizuho | Neutral |
| 2018-02-16 | Herabstufung | Needham | Buy → Hold |
| 2018-01-19 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-01-04 | Bestätigt | Canaccord Genuity | Buy |
| 2018-01-03 | Eingeleitet | Leerink Partners | Mkt Perform |
Alle ansehen
Pacira Biosciences Inc Aktie (PCRX) Neueste Nachrichten
Does Pacira BioSciences Inc. have declining or rising EPSJuly 2025 Snapshot & Verified Momentum Stock Watchlist - khodrobank.com
Reversal indicators forming on Pacira BioSciences Inc. stockQuarterly Portfolio Summary & Daily Stock Trend Watchlist - Newser
What data driven models say about Pacira BioSciences Inc.’s futureWeekly Trade Summary & Safe Entry Momentum Tips - Newser
Pacira BioSciences Inc. stock prediction for this weekEarnings Recap Summary & Community Supported Trade Ideas - Newser
Visual trend scoring systems applied to Pacira BioSciences Inc.Quarterly Profit Report & AI Based Buy/Sell Signal Reports - Newser
Candlestick signals on Pacira BioSciences Inc. stock todayShare Buyback & Verified Trade Idea Suggestions - Newser
Has Pacira BioSciences Inc. formed a bullish divergenceJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
Published on: 2025-09-03 02:53:04 - Newser
Published on: 2025-09-03 02:13:24 - Newser
Chart based exit strategy for Pacira BioSciences Inc.Weekly Profit Analysis & Community Verified Watchlist Alerts - Newser
How to forecast Pacira BioSciences Inc. trends using time seriesJuly 2025 Levels & Risk Controlled Daily Plans - Newser
Live market analysis of Pacira BioSciences Inc.Weekly Trend Report & AI Powered Market Entry Strategies - Newser
Does Pacira BioSciences Inc. have strong fundamentals2025 Institutional Moves & Community Consensus Stock Picks - khodrobank.com
Tools to assess Pacira BioSciences Inc.’s risk profileMarket Growth Report & Comprehensive Market Scan Reports - Newser
Will Pacira BioSciences Inc. rebound enough to break evenJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser
Published on: 2025-09-02 23:10:17 - Newser
Using flow based indicators on Pacira BioSciences Inc.Weekly Trade Recap & Precise Trade Entry Recommendations - Newser
Is Pacira BioSciences Inc. subject to activist investor interestPortfolio Update Report & Daily Entry Point Alerts - khodrobank.com
Is Pacira BioSciences Inc. a strong growth stock2025 Volume Leaders & High Yield Equity Trading Tips - khodrobank.com
Technical signs of recovery in Pacira BioSciences Inc.Recession Risk & Safe Capital Investment Plans - Newser
Risk vs reward if holding onto Pacira BioSciences Inc.Weekly Gains Report & Community Verified Trade Alerts - Newser
Is Pacira BioSciences Inc. stock a value trapJuly 2025 Recap & Low Risk High Win Rate Picks - khodrobank.com
Pacira BioSciences Rises 0.07% on Strong Earnings - AInvest
Why is Pacira BioSciences Inc. stock going downJuly 2025 Earnings & Weekly High Potential Stock Alerts - khodrobank.com
Can Pacira BioSciences Inc. disrupt its industry2025 Dividend Review & Breakout Confirmation Alerts - khodrobank.com
Is Pacira BioSciences Inc. a turnaround storyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - khodrobank.com
Pacira BioSciences Inc. stock trend forecastJuly 2025 Selloffs & Verified Trade Idea Suggestions - Newser
Risk adjusted return profile for Pacira BioSciences Inc. analyzedQuarterly Earnings Report & Safe Capital Growth Stock Tips - Newser
Measuring Pacira BioSciences Inc.’s beta against major indicesPortfolio Growth Summary & Real-Time Market Trend Scan - Newser
How does Pacira BioSciences Inc. score in quality rankings2025 Top Gainers & Safe Entry Trade Reports - khodrobank.com
Institutional scanner results for Pacira BioSciences Inc.July 2025 Fed Impact & Fast Gain Swing Trade Alerts - Newser
Pacira BioSciences Inc. Included in Top Momentum ScanJuly 2025 News Drivers & Weekly Top Gainers Trade List - beatles.ru
Detecting price anomalies in Pacira BioSciences Inc. with AIMarket Risk Report & Smart Allocation Stock Tips - Newser
Automated trading signals detected on Pacira BioSciences Inc.Earnings Performance Report & Weekly Stock Performance Updates - Newser
Real time scanner hits for Pacira BioSciences Inc. explainedMarket Sentiment Review & Weekly High Conviction Trade Ideas - Newser
Best data tools to analyze Pacira BioSciences Inc. stockWeekly Stock Recap & Weekly Breakout Watchlists - Newser
Published on: 2025-08-31 02:11:49 - Newser
Price Reversal in Pacira BioSciences Inc. Traders Watch Closely getLinesFromResByArray error: size == 0 - 더경남뉴스
Finanzdaten der Pacira Biosciences Inc-Aktie (PCRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pacira Biosciences Inc-Aktie (PCRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BIGAL MARCELO | Director |
Aug 07 '25 |
Sale |
23.67 |
4,912 |
116,267 |
11,393 |
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):